WallStSmart
TDAC

Translational Development Acquisition Corp. Ordinary Shares

NASDAQ: TDAC · FINANCIAL SERVICES · SHELL COMPANIES

$10.64
-0.09% today

Updated 2026-06-05

Market cap
$234.85M
P/E ratio
38.29
P/S ratio
EPS (TTM)
$0.28
Dividend yield
52W range
$10 – $11
Volume
0.1M

Translational Development Acquisition Corp. Ordinary Shares (TDAC) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2022202320242025
Revenue$0.00$0.00$0.00
Revenue growth (YoY)
Cost of revenue$320.87M
Gross profit$744.92M
Gross margin
R&D
SG&A$70662.00$485550.00$9.13B$944538.00
Operating income$-70662.00$-485550.00$-196358.00$-944538.00
Operating margin
EBITDA$-485550.00$-71008.00$-944538.00
EBITDA margin
EBIT$-70662.00$-485550.00
Interest expense$508.56M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%
Net income$-70662.00$-485550.00$-71012.00$6.36M
Net income growth (YoY)-587.1%+85.4%+9059.7%
Profit margin

Frequently asked questions

How much free cash flow does TDAC generate?

TDAC produced $-608390.00 in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is TDAC's balance sheet healthy?

TDAC holds $29787.00 in cash and equivalents against — in long-term debt, on $175.12M of shareholder equity. That debt is best read against the cash flow the business throws off each year.